Sponsor
Varian, a Siemens Healthineers Company
Clinical research sponsor
Clinical trials
16 shownA Study Evaluating a New Radiation Treatment Workflow (NGDS)NCT07824583 · lead sponsor · 2026-07-31
RECRUITINGFeasibility Study of CBCT for IGRT in Cancer PatientsNCT06681233 · lead sponsor · 2025-02-19
RECRUITINGDaily Adaptive Radiation Therapy Using an Individualized Approach for Prostate CancerNCT05804318 · lead sponsor · 2023-04-13
RECRUITINGEvaluation of Improved Onboard Patient ImagingNCT06187103 · lead sponsor · 2024-07-10
ACTIVE_NOT_RECRUITINGEvaluation of a Cone-beam CT Scanner for Image Guided RadiotherapyNCT05524454 · lead sponsor · 2023-03-20
COMPLETEDEvaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision RadiotherapyNCT05176860 · lead sponsor · 2022-12-20
COMPLETEDDaily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung CancerNCT05488626 · lead sponsor · 2022-10-20
WITHDRAWNEvaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation TherapyNCT01396551 · lead sponsor · 2010-10-01
COMPLETEDCMT-07-08: The PROstate Bed Evaluation StudyNCT00763152 · lead sponsor · 2008-09-01
COMPLETEDThe AIM Study: Assessing the Impact of Margin ReductionNCT00754000 · lead sponsor · 2008-07-01
COMPLETEDPositioning and Tracking the Prostate During External Beam RadiationNCT00123838 · lead sponsor · 2005-07-01
COMPLETEDPulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung CancerNCT06622174 · collaborator · 2026-08-20
RECRUITINGExternal Beam and Radioligand Radiotherapy for mCRPCNCT07354594 · collaborator · 2026-07-07
RECRUITINGStereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin ReductionNCT07132190 · collaborator · 2025-12-30
RECRUITINGResponse With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy DeliveryNCT07674771 · collaborator · 2026-10-01
NOT_YET_RECRUITINGWide-Angle Tomosynthesis and AI in Diagnostic MammographyNCT07491055 · collaborator · 2026-04-01
NOT_YET_RECRUITINGSponsor roles
lead sponsor11
collaborator5
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.